The global stereotactic surgery devices market was valued at USD 28.5 billion in 2025 and is expected to witness steady growth through the forecast period. By 2035, the market is projected to reach USD 42.7 billion, expanding at a CAGR of 4.1%. Growing incidence of Parkinson’s disease, brain tumors, epilepsy, and other neurological conditions is significantly accelerating demand for...